The estimated Net Worth of Anthony A Mcbride is at least $1.57 Million dollars as of 6 March 2010. Anthony Mcbride owns over 1,412 units of Bristol-Myers Squibb Co stock worth over $1,492,976 and over the last 16 years Anthony sold BMY stock worth over $79,240.
Anthony has made over 4 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently Anthony exercised 1,412 units of BMY stock worth $68,609 on 6 March 2010.
The largest trade Anthony's ever made was exercising 8,383 units of Bristol-Myers Squibb Co stock on 2 March 2010 worth over $407,330. On average, Anthony trades about 1,267 units every 30 days since 2008. As of 6 March 2010 Anthony still owns at least 30,726 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Anthony Mcbride stock trades at the bottom of the page.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: